Synaptogenix Inc (SNPX)

[Cyosol]

"for use in the treatment of central nervous system disorders, lysosomal storage diseases, stroke, cardioprotection and traumatic brain injury"

I would say MS qualifies as a central nervous system disorder, yes.

In fact, if you look at this page, there are an impressive amount of disorders that fall under that same label: https://en.wikipedia.org/wiki/Central_nervous_system_disease

Dr. Wender and Dr. Alkon seem to be good friends too, so I doubt we have to worry about any license issues.